TreeWAS – Variant ID: rs73164810

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I12.0 Hypertensive renal disease with renal failure	0.000	0.953	0.047
G45.9 Transient cerebral ischaemic attack, unspecified	0.023	0.977	0.000
R20.8 Other and unspecified disturbances of skin sensation	0.021	0.979	0.000
I12 Hypertensive renal disease	0.000	0.981	0.019
G45 Transient cerebral ischaemic attacks and related syndromes	0.017	0.983	0.000
E87.6 Hypokalaemia	0.016	0.984	0.000
Z91.5 Personal history of self-harm	0.013	0.987	0.000
G45.8 Other transient cerebral ischaemic attacks and related syndromes	0.013	0.987	0.000
G45.3 Amaurosis fugax	0.013	0.987	0.000
E87 Other disorders of fluid, electrolyte and acid-base balance	0.013	0.987	0.000
G45.2 Multiple and bilateral precerebral artery syndromes	0.012	0.988	0.000
G45.1 Carotid artery syndrome (hemispheric)	0.012	0.988	0.000
G45.0 Vertebro-basilar artery syndrome	0.012	0.988	0.000
E87.0 Hyperosmolality and hypernatraemia	0.012	0.988	0.000
E87.7 Fluid overload	0.012	0.988	0.000
I12.9 Hypertensive renal disease without renal failure	0.000	0.988	0.012
E89.0 Postprocedural hypothyroidism	0.012	0.988	0.000
K76.0 Fatty (change of) liver, not elsewhere classified	0.000	0.988	0.011
G40-G47 Episodic and paroxysmal disorders	0.011	0.989	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.011	0.989	0.000
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.011	0.989	0.000
E70-E90 Metabolic disorders	0.011	0.989	0.000
T39.1 4-Aminophenol derivatives	0.010	0.990	0.000
G47 Sleep disorders	0.010	0.990	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.010	0.990	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.010	0.990	0.000
E87.4 Mixed disorder of acid-base balance	0.010	0.990	0.000
G44 Other headache syndromes	0.010	0.990	0.000
G47.9 Sleep disorder, unspecified	0.010	0.990	0.000
R20 Disturbances of skin sensation	0.010	0.990	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.009	0.990	0.000
G45.4 Transient global amnesia	0.009	0.990	0.000
E88 Other metabolic disorders	0.009	0.991	0.000
K57.9 Diverticular disease of intestine, part unspecified, without perforation or abscess	0.009	0.991	0.000
E87.3 Alkalosis	0.009	0.991	0.000
E89.2 Postprocedural hypoparathyroidism	0.009	0.991	0.000
G46 Vascular syndromes of brain in cerebrovascular diseases	0.009	0.991	0.000
E87.5 Hyperkalaemia	0.009	0.991	0.000
J33.9 Nasal polyp, unspecified	0.009	0.991	0.000
E80.4 Gilbert's syndrome	0.009	0.991	0.000
G47.1 Disorders of excessive somnolence [hypersomnias]	0.009	0.991	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.009	0.991	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.008	0.991	0.000
E74 Other disorders of carbohydrate metabolism	0.008	0.992	0.000
E83 Disorders of mineral metabolism	0.008	0.992	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.008	0.992	0.000
E89.8 Other postprocedural endocrine and metabolic disorders	0.008	0.992	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.008	0.992	0.000
E89.5 Postprocedural testicular hypofunction	0.008	0.992	0.000
E89.4 Postprocedural ovarian failure	0.008	0.992	0.000
E89.1 Postprocedural hypoinsulinaemia	0.008	0.992	0.000
G40 Epilepsy	0.008	0.992	0.000
G47.8 Other sleep disorders	0.008	0.992	0.000
E85 Amyloidosis	0.008	0.992	0.000
G44.2 Tension-type headache	0.008	0.992	0.000
E84 Cystic fibrosis	0.008	0.992	0.000
E79 Disorders of purine and pyrimidine metabolism	0.008	0.992	0.000
E77 Disorders of glycoprotein metabolism	0.008	0.992	0.000
E76 Disorders of glycosaminoglycan metabolism	0.008	0.992	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.008	0.992	0.000
E72 Other disorders of amino-acid metabolism	0.008	0.992	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.008	0.992	0.000
E70 Disorders of aromatic amino-acid metabolism	0.008	0.992	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.008	0.992	0.000
E73 Lactose intolerance	0.008	0.992	0.000
E89.3 Postprocedural hypopituitarism	0.008	0.992	0.000
E87.2 Acidosis	0.008	0.992	0.000
G41 Status epilepticus	0.008	0.992	0.000
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.008	0.992	0.000
T78.0 Anaphylactic shock due to adverse food reaction	0.008	0.992	0.000
M23.36 Other meniscus derangements (Other and unspecified lateral meniscus)	0.008	0.992	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.008	0.992	0.000
G44.0 Cluster headache syndrome	0.007	0.992	0.000
G47.4 Narcolepsy and cataplexy	0.007	0.992	0.000
G47.2 Disorders of the sleep-wake schedule	0.007	0.992	0.000
G44.8 Other specified headache syndromes	0.007	0.993	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.007	0.993	0.000
T39.4 Antirheumatics, not elsewhere classified	0.007	0.993	0.000
T39.2 Pyrazolone derivatives	0.007	0.993	0.000
G46.4 Cerebellar stroke syndrome	0.007	0.993	0.000
M23.3 Other meniscus derangements	0.007	0.993	0.000
G44.4 Drug-induced headache, not elsewhere classified	0.007	0.993	0.000
G44.3 Chronic posttraumatic headache	0.007	0.993	0.000
G44.1 Vascular headache, not elsewhere classified	0.007	0.993	0.000
G43 Migraine	0.007	0.993	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.007	0.993	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.007	0.993	0.000
E80.6 Other disorders of bilirubin metabolism	0.007	0.993	0.000
E80.5 Crigler-Najjar syndrome	0.007	0.993	0.000
E80.3 Defects of catalase and peroxydase	0.007	0.993	0.000
E80.2 Other porphyria	0.007	0.993	0.000
E80.1 Porphyria cutanea tarda	0.007	0.993	0.000
E80.0 Hereditary erythropoietic porphyria	0.007	0.993	0.000
R20.3 Hyperaesthesia	0.007	0.993	0.000
R20.1 Hypoaesthesia of skin	0.007	0.993	0.000
R20.0 Anaesthesia of skin	0.007	0.993	0.000
R20.2 Paraesthesia of skin	0.007	0.993	0.000
T78 Adverse effects, not elsewhere classified	0.007	0.993	0.000
E88.9 Metabolic disorder, unspecified	0.007	0.993	0.000
E88.8 Other specified metabolic disorders	0.007	0.993	0.000
E88.3 Tumour lysis syndrome	0.007	0.993	0.000
E88.2 Lipomatosis, not elsewhere classified	0.007	0.993	0.000
E88.1 Lipodystrophy, not elsewhere classified	0.007	0.993	0.000
M23.30 Other meniscus derangements (Multiple sites)	0.007	0.993	0.000
M23 Internal derangement of knee	0.007	0.993	0.000
N18.9 Chronic renal failure, unspecified	0.000	0.993	0.007
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.007	0.993	0.000
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.007	0.993	0.000
G46.8 Other vascular syndromes of brain in cerebrovascular diseases	0.007	0.993	0.000
G46.7 Other lacunar syndromes	0.007	0.993	0.000
G46.6 Pure sensory lacunar syndrome	0.007	0.993	0.000
G46.5 Pure motor lacunar syndrome	0.007	0.993	0.000
G46.3 Brain stem stroke syndrome	0.007	0.993	0.000
G46.2 Posterior cerebral artery syndrome	0.007	0.993	0.000
G46.1 Anterior cerebral artery syndrome	0.007	0.993	0.000
G46.0 Middle cerebral artery syndrome	0.007	0.993	0.000
K02.9 Dental caries, unspecified	0.007	0.993	0.000
M23.5 Chronic instability of knee	0.007	0.993	0.000
G40.8 Other epilepsy	0.007	0.993	0.000
J33 Nasal polyp	0.007	0.993	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.007	0.993	0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.007	0.993	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.006	0.993	0.000
J33.8 Other polyp of sinus	0.007	0.993	0.000
M23.51 Chronic instability of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.006	0.993	0.000
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)	0.006	0.994	0.000
E83.4 Disorders of magnesium metabolism	0.006	0.994	0.000
E83.3 Disorders of phosphorus metabolism	0.006	0.994	0.000
E85.9 Amyloidosis, unspecified	0.006	0.994	0.000
G43.0 Migraine without aura [common migraine]	0.006	0.994	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.006	0.994	0.000
G47.0 Disorders of initiating and maintaining sleep [insomnias]	0.006	0.994	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.006	0.994	0.000
E74.9 Disorder of carbohydrate metabolism, unspecified	0.006	0.994	0.000
E74.8 Other specified disorders of carbohydrate metabolism	0.006	0.994	0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.006	0.994	0.000
E74.2 Disorders of galactose metabolism	0.006	0.994	0.000
E74.1 Disorders of fructose metabolism	0.006	0.994	0.000
E74.0 Glycogen storage disease	0.006	0.994	0.000
T36 Poisoning by systemic antibiotics	0.006	0.994	0.000
I26.9 Pulmonary embolism without mention of acute cor pulmonale	0.006	0.994	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.006	0.994	0.000
E83.8 Other disorders of mineral metabolism	0.006	0.994	0.000
E83.2 Disorders of zinc metabolism	0.006	0.994	0.000
E83.0 Disorders of copper metabolism	0.006	0.994	0.000
G40.7 Petit mal, unspecified, without grand mal seizures	0.006	0.994	0.000
G40.4 Other generalised epilepsy and epileptic syndromes	0.006	0.994	0.000
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.006	0.994	0.000
M23.4 Loose body in knee	0.006	0.994	0.000
E83.5 Disorders of calcium metabolism	0.006	0.994	0.000
E83.1 Disorders of iron metabolism	0.006	0.994	0.000
E85.8 Other amyloidosis	0.006	0.994	0.000
E85.3 Secondary systemic amyloidosis	0.006	0.994	0.000
E85.2 Heredofamilial amyloidosis, unspecified	0.006	0.994	0.000
E85.1 Neuropathic heredofamilial amyloidosis	0.006	0.994	0.000
E85.0 Nonneuropathic heredofamilial amyloidosis	0.006	0.994	0.000
T78.4 Allergy, unspecified	0.006	0.994	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.006	0.994	0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.006	0.994	0.000
E70.8 Other disorders of aromatic amino-acid metabolism	0.006	0.994	0.000
E70.3 Albinism	0.006	0.994	0.000
E70.2 Disorders of tyrosine metabolism	0.006	0.994	0.000
E70.1 Other hyperphenylalaninaemias	0.006	0.994	0.000
E70.0 Classical phenylketonuria	0.006	0.994	0.000
E71.3 Disorders of fatty-acid metabolism	0.006	0.994	0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.006	0.994	0.000
E71.1 Other disorders of branched-chain amino-acid metabolism	0.006	0.994	0.000
E71.0 Maple-syrup-urine disease	0.006	0.994	0.000
E72.9 Disorder of amino-acid metabolism, unspecified	0.006	0.994	0.000
E72.8 Other specified disorders of amino-acid metabolism	0.006	0.994	0.000
E72.5 Disorders of glycine metabolism	0.006	0.994	0.000
E72.4 Disorders of ornithine metabolism	0.006	0.994	0.000
E72.3 Disorders of lysine and hydroxylysine metabolism	0.006	0.994	0.000
E72.2 Disorders of urea cycle metabolism	0.006	0.994	0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.006	0.994	0.000
E72.0 Disorders of amino-acid transport	0.006	0.994	0.000
E75.6 Lipid storage disorder, unspecified	0.006	0.994	0.000
E75.5 Other lipid storage disorders	0.006	0.994	0.000
E75.4 Neuronal ceroid lipofuscinosis	0.006	0.994	0.000
E75.3 Sphingolipidosis, unspecified	0.006	0.994	0.000
E75.2 Other sphingolipidosis	0.006	0.994	0.000
E75.1 Other gangliosidosis	0.006	0.994	0.000
E75.0 GM2 gangliosidosis	0.006	0.994	0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.006	0.994	0.000
E76.8 Other disorders of glucosaminoglycan metabolism	0.006	0.994	0.000
E76.3 Mucopolysaccharidosis, unspecified	0.006	0.994	0.000
E76.2 Other mucopolysaccharidoses	0.006	0.994	0.000
E76.1 Mucopolysaccharidosis, type II	0.006	0.994	0.000
E76.0 Mucopolysaccharidosis, type I	0.006	0.994	0.000
E77.9 Disorder of glycoprotein metabolism, unspecified	0.006	0.994	0.000
E77.8 Other disorders of glycoprotein metabolism	0.006	0.994	0.000
E77.1 Defects in glycoprotein degradation	0.006	0.994	0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.006	0.994	0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.006	0.994	0.000
E79.8 Other disorders of purine and pyrimidine metabolism	0.006	0.994	0.000
E79.1 Lesch-Nyhan syndrome	0.006	0.994	0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.006	0.994	0.000
E84.9 Cystic fibrosis, unspecified	0.006	0.994	0.000
E84.8 Cystic fibrosis with other manifestations	0.006	0.994	0.000
E84.1 Cystic fibrosis with intestinal manifestations	0.006	0.994	0.000
E84.0 Cystic fibrosis with pulmonary manifestations	0.006	0.994	0.000
E73.8 Other lactose intolerance	0.006	0.994	0.000
E73.1 Secondary lactase deficiency	0.006	0.994	0.000
E73.0 Congenital lactase deficiency	0.006	0.994	0.000
E73.9 Lactose intolerance, unspecified	0.006	0.994	0.000
E85.4 Organ-limited amyloidosis	0.006	0.994	0.000
T78.8 Other adverse effects, not elsewhere classified	0.006	0.994	0.000
C78.0 Secondary malignant neoplasm of lung	0.006	0.994	0.000
T39.0 Salicylates	0.006	0.994	0.000
T78.3 Angioneurotic oedema	0.006	0.994	0.000
G41.8 Other status epilepticus	0.006	0.994	0.000
G41.2 Complex partial status epilepticus	0.006	0.994	0.000
G41.1 Petit mal status epilepticus	0.006	0.994	0.000
G41.0 Grand mal status epilepticus	0.006	0.994	0.000
T43.2 Other and unspecified antidepressants	0.006	0.994	0.000
M34 Systemic sclerosis	0.006	0.994	0.000
G40.5 Special epileptic syndromes	0.006	0.994	0.000
T78.1 Other adverse food reactions, not elsewhere classified	0.006	0.994	0.000
M34.1 CR(E)ST syndrome	0.006	0.994	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.006	0.994	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.006	0.994	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.006	0.994	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.006	0.994	0.000
M23.8 Other internal derangements of knee	0.006	0.994	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.006	0.994	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.005	0.994	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.006	0.994	0.000
M23.37 Other meniscus derangements-Capsular lig	0.005	0.994	0.000
M23.49 Loose body in knee-Unspec lig/men	0.005	0.995	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.005	0.995	0.000
T66-T78 Other and unspecified effects of external causes	0.005	0.995	0.000
G43.3 Complicated migraine	0.005	0.995	0.000
G43.2 Status migrainosus	0.005	0.995	0.000
T45.5 Anticoagulants	0.005	0.995	0.000
T43.9 Psychotropic drug, unspecified	0.005	0.995	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
T43.6 Psychostimulants with abuse potential	0.005	0.995	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.005	0.995	0.000
M23.31 Other meniscus derangements (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.005	0.995	0.000
T45.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.005	0.995	0.000
M23.59 Chronic instability of knee (Unspecified ligament or Unspecified meniscus)	0.005	0.995	0.000
T78.9 Adverse effect, unspecified	0.005	0.995	0.000
T36.0 Penicillins	0.005	0.995	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.005	0.995	0.000
T71 Asphyxiation	0.005	0.995	0.000
M23.9 Internal derangement of knee, unspecified	0.005	0.995	0.000
M23.1 Discoid meniscus (congenital)	0.005	0.995	0.000
M34.9 Systemic sclerosis, unspecified	0.005	0.995	0.000
Z08 Follow-up examination after treatment for malignant neoplasm	0.000	0.995	0.005
G43.8 Other migraine	0.005	0.995	0.000
M23.0 Cystic meniscus	0.005	0.995	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.005	0.995	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.005	0.995	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.005	0.995	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.005	0.995	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.005	0.995	0.000
T44.0 Anticholinesterase agents	0.005	0.995	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.005	0.995	0.000
M20-M25 Other joint disorders	0.005	0.995	0.000
M23.6 Other spontaneous disruption of ligament(s) of knee	0.005	0.995	0.000
Z08.0 Follow-up examination after surgery for malignant neoplasm	0.000	0.995	0.005
M23.57 Chronic instability of knee (Capsular ligament)	0.005	0.995	0.000
M23.56 Chronic instability of knee (Other and unspecified lateral meniscus)	0.005	0.995	0.000
M23.55 Chronic instability of knee (Posterior horn of lateral meniscus)	0.005	0.995	0.000
M23.54 Chronic instability of knee (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.005	0.995	0.000
M23.53 Chronic instability of knee (Medial collateral ligament or Other and unspecified medial meniscus)	0.005	0.995	0.000
M23.52 Chronic instability of knee (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.005	0.995	0.000
M23.50 Chronic instability of knee (Multiple sites)	0.005	0.995	0.000
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.000	0.995	0.005
J33.1 Polypoid sinus degeneration	0.005	0.995	0.000
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.005	0.995	0.000
T51.0 Ethanol	0.005	0.995	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.005	0.995	0.000
G41.9 Status epilepticus, unspecified	0.005	0.995	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.005	0.995	0.000
T45.8 Other primarily systemic and haematological agents	0.005	0.995	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.005	0.995	0.000
T45.6 Fibrinolysis-affecting drugs	0.005	0.995	0.000
T45.4 Iron and its compounds	0.005	0.995	0.000
T45.3 Enzymes, not elsewhere classified	0.005	0.995	0.000
T45.2 Vitamins, not elsewhere classified	0.005	0.995	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.005	0.995	0.000
M23.35 Other meniscus derangements (Posterior horn of lateral meniscus)	0.005	0.995	0.000
M23.43 Loose body in knee-Med lig/oth men	0.005	0.995	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.005	0.995	0.000
T36.9 Systemic antibiotic, unspecified	0.005	0.995	0.000
T36.8 Other systemic antibiotics	0.005	0.995	0.000
T36.7 Antifungal antibiotics, systemically used	0.005	0.995	0.000
T36.6 Rifamycins	0.005	0.995	0.000
T36.5 Aminoglycosides	0.005	0.995	0.000
T36.4 Tetracyclines	0.005	0.995	0.000
T36.3 Macrolides	0.005	0.995	0.000
T36.2 Chloramphenicol group	0.005	0.995	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.005	0.995	0.000
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.000	0.995	0.005
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.000	0.995	0.005
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.005	0.995	0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.005	0.995	0.000
N18.3 Chronic kidney disease, stage 3	0.000	0.995	0.005
T78.2 Anaphylactic shock, unspecified	0.005	0.995	0.000
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm	0.000	0.995	0.005
M23.47 Loose body in knee-Capsular lig	0.005	0.995	0.000
M23.46 Loose body in knee-O/unsp lat men	0.005	0.995	0.000
M23.45 Loose body in knee-Pst hrn lat men	0.005	0.995	0.000
M23.44 Loose body in knee-Lat lig/ant men	0.005	0.995	0.000
M23.42 Loose body in knee-Pst lig/hrn men	0.005	0.995	0.000
M23.41 Loose body in knee-Ant lig/hrn men	0.005	0.995	0.000
M23.40 Loose body in knee-Mult sites	0.005	0.995	0.000
M34.8 Other forms of systemic sclerosis	0.005	0.995	0.000
M23.39 Other meniscus derangements (Unspecified ligament or Unspecified meniscus)	0.005	0.995	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.004	0.995	0.000
G43.1 Migraine with aura [classical migraine]	0.004	0.995	0.000
M23.82 Other internal derangements of knee (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.004	0.995	0.000
M23.83 Other internal derangements of knee (Medial collateral ligament or Other and unspecified medial meniscus)	0.004	0.996	0.000
D13.1 Stomach	0.000	0.996	0.004
M23.86 Other internal derangements of knee (Other and unspecified lateral meniscus)	0.004	0.996	0.000
M23.80 Other internal derangements of knee (Multiple sites)	0.004	0.996	0.000
J33.0 Polyp of nasal cavity	0.004	0.996	0.000
M34.2 Systemic sclerosis induced by drugs and chemicals	0.004	0.996	0.000
M34.0 Progressive systemic sclerosis	0.004	0.996	0.000
M23.25 Derangement of meniscus due to old tear or injury (Posterior horn of lateral meniscus)	0.004	0.996	0.000
J32.9 Chronic sinusitis, unspecified	0.004	0.996	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T37.5 Antiviral drugs	0.004	0.996	0.000
T37.4 Anthelminthics	0.004	0.996	0.000
T37.3 Other antiprotozoal drugs	0.004	0.996	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
T37.1 Antimycobacterial drugs	0.004	0.996	0.000
T37.0 Sulphonamides	0.004	0.996	0.000
T41.5 Therapeutic gases	0.004	0.996	0.000
T41.4 Anaesthetic, unspecified	0.004	0.996	0.000
T41.3 Local anaesthetics	0.004	0.996	0.000
T41.2 Other and unspecified general anaesthetics	0.004	0.996	0.000
T41.1 Intravenous anaesthetics	0.004	0.996	0.000
T41.0 Inhaled anaesthetics	0.004	0.996	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.996	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.004	0.996	0.000
T48.5 Anti-common-cold drugs	0.004	0.996	0.000
T48.4 Expectorants	0.004	0.996	0.000
T48.3 Antitussives	0.004	0.996	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.004	0.996	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.996	0.000
T48.0 Oxytocic drugs	0.004	0.996	0.000
T49.9 Topical agent, unspecified	0.004	0.996	0.000
T49.8 Other topical agents	0.004	0.996	0.000
T49.7 Dental drugs, topically applied	0.004	0.996	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.004	0.996	0.000
T49.5 Ophthalmological drugs and preparations	0.004	0.996	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.996	0.000
T49.3 Emollients, demulcents and protectants	0.004	0.996	0.000
T49.2 Local astringents and local detergents	0.004	0.996	0.000
T49.1 Antipruritics	0.004	0.996	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.004	0.996	0.000
M23.87 Other internal derangements of knee (Capsular ligament)	0.004	0.996	0.000
M23.85 Other internal derangements of knee (Posterior horn of lateral meniscus)	0.004	0.996	0.000
M23.84 Other internal derangements of knee (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.004	0.996	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.004	0.996	0.000
I20.8 Other forms of angina pectoris	0.000	0.996	0.004
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.004	0.996	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.004	0.996	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
T47.7 Emetics	0.004	0.996	0.000
T47.6 Antidiarrhoeal drugs	0.004	0.996	0.000
T47.5 Digestants	0.004	0.996	0.000
T47.4 Other laxatives	0.004	0.996	0.000
T47.3 Saline and osmotic laxatives	0.004	0.996	0.000
T47.2 Stimulant laxatives	0.004	0.996	0.000
T47.0 Histamine H(2)-receptor antagonists	0.004	0.996	0.000
M21 Other acquired deformities of limbs	0.004	0.996	0.000
T38.9 Other and unspecified hormone antagonists	0.004	0.996	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.004	0.996	0.000
T38.7 Androgens and anabolic congeners	0.004	0.996	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.004	0.996	0.000
T38.5 Other oestrogens and progestogens	0.004	0.996	0.000
T38.4 Oral contraceptives	0.004	0.996	0.000
T38.2 Antithyroid drugs	0.004	0.996	0.000
T38.1 Thyroid hormones and substitutes	0.004	0.996	0.000
T38.0 Glucocorticoids and synthetic analogues	0.004	0.996	0.000
T75 Effects of other external causes	0.004	0.996	0.000
T74 Maltreatment syndromes	0.004	0.996	0.000
T73 Effects of other deprivation	0.004	0.996	0.000
T70 Effects of air pressure and water pressure	0.004	0.996	0.000
T69 Other effects of reduced temperature	0.004	0.996	0.000
T67 Effects of heat and light	0.004	0.996	0.000
T66 Unspecified effects of radiation	0.004	0.996	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.004	0.996	0.000
G47.3 Sleep apnoea	0.004	0.996	0.000
M24.4 Recurrent dislocation and subluxation of joint	0.004	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
T46.7 Peripheral vasodilators	0.004	0.996	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
T46.1 Calcium-channel blockers	0.004	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
T51 Toxic effect of alcohol	0.004	0.996	0.000
J31.0 Chronic rhinitis	0.004	0.996	0.000
M23.2 Derangement of meniscus due to old tear or injury	0.004	0.996	0.000
M30 Polyarteritis nodosa and related conditions	0.004	0.996	0.000
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.004	0.996	0.000
M32 Systemic lupus erythematosus	0.004	0.996	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.004	0.996	0.000
R45.1 Restlessness and agitation	0.004	0.996	0.000
M23.19 Discoid meniscus (congenital) (Unspecified ligament or Unspecified meniscus)	0.004	0.996	0.000
M23.17 Discoid meniscus (congenital)-Capsular lig	0.004	0.996	0.000
M23.16 Discoid meniscus (congenital) (Other and unspecified lateral meniscus)	0.004	0.996	0.000
M23.15 Discoid meniscus (congenital) (Posterior horn of lateral meniscus)	0.004	0.996	0.000
M23.14 Discoid meniscus (congenital) (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.004	0.996	0.000
M23.13 Discoid meniscus (congenital) (Medial collateral ligament or Other and unspecified medial meniscus)	0.004	0.996	0.000
M23.12 Discoid meniscus (congenital) (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.004	0.996	0.000
M23.11 Discoid meniscus (congenital) (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.004	0.996	0.000
M23.10 Discoid meniscus (congenital) (Multiple sites)	0.004	0.996	0.000
M23.99 Internal derangement of knee, unspecified (Unspecified ligament or Unspecified meniscus)	0.004	0.996	0.000
M23.97 Internal derangement of knee, unspecified (Capsular ligament)	0.004	0.996	0.000
M23.96 Internal derangement of knee, unspecified (Other and unspecified lateral meniscus)	0.004	0.996	0.000
M23.95 Internal derangement of knee, unspecified (Posterior horn of lateral meniscus)	0.004	0.996	0.000
M23.94 Internal derangement of knee, unspecified (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.004	0.996	0.000
M23.93 Internal derangement of knee, unspecified (Medial collateral ligament or Other and unspecified medial meniscus)	0.004	0.996	0.000
M23.92 Internal derangement of knee, unspecified (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.004	0.996	0.000
M23.91 Internal derangement of knee, unspecified (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.004	0.996	0.000
M23.90 Internal derangement of knee, unspecified (Multiple sites)	0.004	0.996	0.000
Z08.8 Follow-up examination after other treatment for malignant neoplasm	0.000	0.996	0.004
M23.09 Cystic meniscus (Unspecified ligament or Unspecified meniscus)	0.004	0.996	0.000
M23.07 Cystic meniscus-Capsular lig	0.004	0.996	0.000
M23.06 Cystic meniscus (Other and unspecified lateral meniscus)	0.004	0.996	0.000
M23.05 Cystic meniscus (Posterior horn of lateral meniscus)	0.004	0.996	0.000
M23.04 Cystic meniscus (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.004	0.996	0.000
M23.02 Cystic meniscus (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.004	0.996	0.000
M23.01 Cystic meniscus (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.004	0.996	0.000
M23.00 Cystic meniscus (Multiple sites)	0.004	0.996	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
G95.2 Cord compression, unspecified	0.004	0.996	0.000
M23.34 Other meniscus derangements (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.004	0.996	0.000
F33.9 Recurrent depressive disorder, unspecified	0.004	0.996	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
E04.9 Non-toxic goitre, unspecified	0.004	0.996	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
M36 Systemic disorders of connective tissue in diseases classified elsewhere	0.004	0.996	0.000
M33 Dermatopolymyositis	0.004	0.996	0.000
M23.69 Other spontaneous disruption of ligament(s) of knee (Unspecified ligament or Unspecified meniscus)	0.004	0.996	0.000
M23.67 Other spontaneous disruption of ligament(s) of knee (Capsular ligament)	0.004	0.996	0.000
M23.66 Other spontaneous disruption of ligament(s) of knee-O/unsp	0.004	0.996	0.000
M23.65 Other spontaneous disruption of ligament(s) of knee-Pst hrn	0.004	0.996	0.000
M23.64 Other spontaneous disruption of ligament(s) of knee (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.004	0.996	0.000
M23.63 Other spontaneous disruption of ligament(s) of knee (Medial collateral ligament or Other and unspecified medial meniscus)	0.004	0.996	0.000
M23.62 Other spontaneous disruption of ligament(s) of knee (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.004	0.996	0.000
M23.60 Other spontaneous disruption of ligament(s) of knee (Multiple sites)	0.004	0.996	0.000
M24.47 Recurrent dislocation and subluxation of joint (Ankle and foot)	0.004	0.996	0.000
C78.7 Secondary malignant neoplasm of liver	0.004	0.996	0.000
M23.03 Cystic meniscus (Medial collateral ligament or Other and unspecified medial meniscus)	0.004	0.996	0.000
T68 Hypothermia	0.004	0.996	0.000
M24 Other specific joint derangements	0.004	0.996	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.004	0.996	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.004	0.996	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.004	0.996	0.000
T42.3 Barbiturates	0.004	0.996	0.000
T42.2 Succinimides and oxazolidinediones	0.004	0.996	0.000
T42.0 Hydantoin derivatives	0.004	0.996	0.000
I10-I15 Hypertensive diseases	0.000	0.996	0.004
M25.57 Pain in joint (Ankle and foot)	0.004	0.996	0.000
M25 Other joint disorders, not elsewhere classified	0.004	0.996	0.000
G90-G99 Other disorders of the nervous system	0.004	0.996	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.004	0.996	0.000
O34.2 Maternal care due to uterine scar from previous surgery	0.004	0.996	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.004	0.996	0.000
N18 Chronic renal failure	0.000	0.996	0.004
M24.41 Recurrent dislocation and subluxation of joint (Shoulder region)	0.004	0.996	0.000
G43.9 Migraine, unspecified	0.004	0.996	0.000
O34.8 Maternal care for other abnormalities of pelvic organs	0.004	0.996	0.000
O34 Maternal care for known or suspected abnormality of pelvic organs	0.004	0.996	0.000
M23.61 Other spontaneous disruption of ligament(s) of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.004	0.996	0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.004	0.996	0.000
T42.1 Iminostilbenes	0.004	0.996	0.000
D86.0 Sarcoidosis of lung	0.004	0.996	0.000
M21.7 Unequal limb length (acquired)	0.004	0.996	0.000
M23.29 Derangement of meniscus due to old tear or injury (Unspecified ligament or Unspecified meniscus)	0.004	0.996	0.000
M21.6 Other acquired deformities of ankle and foot	0.004	0.996	0.000
D86 Sarcoidosis	0.004	0.996	0.000
F33 Recurrent depressive disorder	0.004	0.996	0.000
G95 Other diseases of spinal cord	0.004	0.996	0.000
K02 Dental caries	0.004	0.996	0.000
M21.4 Flat foot [pes planus] (acquired)	0.003	0.996	0.000
O03.4 Incomplete, without complication	0.004	0.996	0.000
T50.8 Diagnostic agents	0.003	0.996	0.000
T50.7 Analeptics and opioid receptor antagonists	0.003	0.996	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.996	0.000
T50.5 Appetite depressants	0.003	0.996	0.000
T50.4 Drugs affecting uric acid metabolism	0.003	0.996	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.996	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.996	0.000
T50.1 Loop [high-ceiling] diuretics	0.003	0.996	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.996	0.000
Chapter VI Diseases of the nervous system	0.004	0.996	0.000
T51.9 Alcohol, unspecified	0.003	0.996	0.000
M35 Other systemic involvement of connective tissue	0.004	0.996	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations